Dose Response Bioavailability of Coffee and Green Tea Antioxidants in Humans
NCT ID: NCT01089920
Last Updated: 2014-06-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
23 participants
INTERVENTIONAL
2009-09-30
2010-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Bioavailability of Green Tea and Coffee Polyphenols
NCT03248115
Coffee Polyphenols Antioxidants
NCT01832662
Bioavailability of Chlorogenic and Phenolic Acids From Soluble Coffees
NCT01400386
Absorption of Phenolic Acids From Coffee in Humans
NCT01912144
Influence of Breakfast Consumption on Chlorogenic Acid Metabolism in Humans
NCT01523028
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High dose coffee
High dose of polyphenols from soluble coffee
Coffee
Soluble coffee commercially available
Medium dose coffee
Medium dose of polyphenols from soluble coffee
Coffee
Soluble coffee commercially available
Low dose coffee
Low dose of polyphenols from soluble coffee
Coffee
Soluble coffee commercially available
High dose green tea
High dose of green tea polyphenols from infusion
Green tea
Infusion (tea bags) from commercially available green tea
Medium dose green tea infusion
Medium dose of green polyphenols from infusion
Green tea
Infusion (tea bags) from commercially available green tea
Low dose green tea infusion
low dose of polyphenols from an infusion of green tea
Green tea
Infusion (tea bags) from commercially available green tea
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Green tea
Infusion (tea bags) from commercially available green tea
Coffee
Soluble coffee commercially available
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Healthy as determined by the medical questionnaire and the medical visit
* Normal weight: BMI 18 - 25
* Coffee drinkers with an average consumption of 2-5 cups per day
* Having given informed consent
Exclusion Criteria
* Have had a gastrointestinal surgery, except appendicectomy
* Difficulty to swallow
* Have a regular consumption of medication
* Have taken antibiotic therapy within the last 6 months
* Alcohol consumption \> 2 units a day
* Smokers (more than 5 cigarettes per day)
* Have given blood within the last 3 weeks
* Volunteers who cannot be expected to comply with treatment
* Currently participating or having participated in another clinical trial during the last 3 weeks
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Société des Produits Nestlé (SPN)
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maurice Beaumont, M.D., Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Nestec
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nestle Research Center
Lausanne, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
09.06.MET
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.